88 FR 73 pg. 23428 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA-PS23-001, Increasing PrEP Use Among Black Cisgender Women in the United States (HerPrEP) and RFA-PS23-005, Expanding Rapid Initiation of Antiretroviral Therapy in Non-Traditional Settings: Emergency Department; Amended Notice of Closed Meeting
Type: NOTICEVolume: 88Number: 73Page: 23428
Page: 23428FR document: [FR Doc. 2023-07991 Filed 4-14-23; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-PS23-001, Increasing PrEP Use Among Black Cisgender Women in the United States (HerPrEP) and RFA-PS23-005, Expanding Rapid Initiation of Antiretroviral Therapy in Non-Traditional Settings: Emergency Department; Amended Notice of Closed Meeting
Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-PS-23-001, Increasing PrEP Use Among Black Cisgender Women in the United States (HerPrEP), and RFA-PS-23-005, Expanding Rapid Initiation of Antiretroviral Therapy in Non-traditional Settings: Emergency Department; May 24-25, 2023, 10 a.m.-5 p.m. EDT, Teleconference, Centers for Disease Control and Prevention, Room 1077, 8 Corporate Blvd., Atlanta, GA 30329 in the original Federal Register Notice. The meeting was published in the Federal Register on March 8, 2023, Volume 88, Number 45, pages 14372-14373.
The meeting is being amended to remove the second day of the meeting. The notice should read as follows:
Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-PS-23-001, Increasing PrEP Use Among Black Cisgender Women in the United States (HerPrEP), and RFA-PS-23-005, Expanding Rapid Initiation of Antiretroviral Therapy in Non-traditional Settings: Emergency Department.
Date: May 24, 2023.
Time: 10 a.m.-5 p.m., EDT.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
Gregory Anderson, M.S., M.P.H., Scientific Review Officer, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US8-1, Atlanta, Georgia 30329-4027. Telephone: (404) 718-8833; Email: GAnderson@cdc.gov.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-07991 Filed 4-14-23; 8:45 am]
BILLING CODE 4163-18-P